Observational Study on the Long Term Safety of Kuvan® Treatment in Patients With Hyperphenylalaninemia (HPA) Due to Phenylketonuria (PKU) or BH4 Deficiency
Clinical trial NCT01016392 · COMPLETED
Trial details
- NCT number
- NCT01016392
- Sponsor
- BioMarin Pharmaceutical
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2009-12-01
- Primary completion
- 2021-05-31
- Enrollment
- 627
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.